title: The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
authors.affiliation: University of Lucerne, Switzerland.
authors.forename: Kai P
authors.initials: KP
authors.lastname: Purnhagen
mesh_terms: D003469:Culture; D017277:Drug Approval / Q000191:economics / Q000266:history / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D004992:Ethics, Medical; D005060:Europe; D033161:Government Regulation / Q000266:history; D049673:History, 20th Century; D006801:Humans; D007391:International Cooperation; D038622:Internationality / Q000266:history / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug; D011358:Product Surveillance, Postmarketing; D011785:Quality Assurance, Health Care; D012306:Risk; D012945:Social Values; D014481:United States; D014486:United States Food and Drug Administration